November 18, 2026  -  Digital Health, Investment, PMOS

Hone Health Raises $228M, Expands Women’s Health Offering

Hone Health

Hone Health has raised $228 million to scale its telehealth platform and expand its care pathways. 

 

The round included $28 million in equity as Series A financing led by MarcyPen Capital Partners and $200 million growth financing from General Catalyst’s Customer Value Fund (CVF). Additional participants included Pentland Ventures, Gwyneth Paltrow’s Kinship Ventures, Hanwha, Gannet Capital, humbition, and Comma Capital.

 

Hone’s latest raise will support advanced diagnostics, clinical technology, emerging therapies, research and trials, and broader clinical care. 

 

Expanding its women’s health offering, the platform is also adding a new PMOS care pathway. 

 

“Being able to expand our PMOS offerings is a function of offering more labs, expanding the medications that we offer, and making sure our physicians feel comfortable treating it,” said Saad Alam, Co-Founder & CEO of Hone Health. 

 

Beyond PMOS, the company has doubled down on long-term postpartum support for women and plans to invest in research efforts across life stages and treatments like hormone replacement therapy, per Alam. 

 

“We are one of the larger providers of testosterone for women in the country. Because we’ve been capturing longitudinal data on every one of our women’s health patients since we’ve begun, we have been able to, and will continue to, conduct research on the appropriate doses – both by itself and in combination with other medications,” he said. 

 

In addition to the raise and expansion, the company also announced the launch of Hone Black, its most comprehensive membership – offering advanced diagnostics, treatments, and ongoing medical care for a personalized, concierge experience.



Femtech Insider
Femtech Insider